Vasodilatation produced by orientin and its mechanism study

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 1, 2005, Pages 37-41

  Fu, Xiao Chun ^a   Wang, Min Wei ^a   Li, Shao Peng ^b   Zhang, Ying ^c   Wang, Huai Liang ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Cyclic nucleotide; Endothelium; Nitric oxide (NO); Orientin; Rabbit thoracic aorta; Vasorelaxant

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHLORIDE; CALCIUM ION; CYCLIC AMP; CYCLIC GMP; INDOMETACIN; ISOORIENTIN; ISOVITEXIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; ORIENTIN; PHENYLEPHRINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHLORIDE; PROPRANOLOL; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; TETRYLAMMONIUM CHLORIDE; VITEXIN; VOLTAGE GATED CALCIUM CHANNEL; CALCIUM CHANNEL; FLAVONOID; GLUCOSIDE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PHYLLOSTACHYS NIGRA; PLANT; PLANT LEAF; RABBIT; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; VASCULAR RING; VASOCONSTRICTION; VASODILATATION; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANIMALS; AORTA, THORACIC; CALCIUM CHANNELS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GLUCOSIDES; NITRIC OXIDE; RABBITS; VASODILATION;

EID: 18444400209     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.37     Document Type: Article

References (26)

1. Zhang Y., Wu X. Q., Yu Z. Y., J. Trad. Chi. Med., 27, 254-257, 320 (2002).
2. Dietrych-Szostak D., Oleszek W., J. Agric. Food Chem., 47, 4384-4387 (1999).
3. Okuyama E., Okamoto Y., Yamazaki M., Satake M., Chem. Pharm. Bull., 44, 333-336 (1996).
4. Soulimani R., Younos C., Jarmouni S., Bousta D., Misslin R., Mortier F., J. Ethnopharmacol., 57, 11-20 (1997).
5. Li Y. L., Ma S. C., Yang Y. T., Ye S. M., But P. P., J. Eihnopharmacol., 79, 365-368 (2002).
6. Budzianowski J., Pakulski G., Robak J., Pol. J. Pharmacol. Pharm., 43, 395-401 (1991).
7. Nakamura Y., Matsumoto H., Todoki K., Jpn. J. Pharmacol., 89, 29-35 (2002).
8. Li H. F., Zhen T. Z., Li W., J. Lanzhou Univer. (Nature Science), 37, 119-122 (2001).
9. Nyhan D., Gaine S., Hales M., J. Cardiovasc. Pharmacol., 34, 518-525 (1999).
10. Wang G. J., Shan J., Pang M. C. M., Chou G. J., Chen C. F., J. Pharmacol. Exp. Ther., 276, 1016-1021 (1996).
11. Luo W. B., Wang Y. P., Acta Pharmacol. Sin., 22, 1135-1142 (2001).
12. Wang G. J., Wu X. C., Chen C. F., J. Pharmacol. Exp. Ther., 289, 1237-1244 (1999).
13. Iwata S., Saito S., Kon-ya K., Eur. J. Pharmacol., 432, 63-70 (2001).
14. Lowry O. H., Rosebrough N. J., Farr A. L., J. Biol. Chem., 193, 265-275 (1951).
15. Shi C. C., Chen S. Y., Wang G. J., Eur. J. Pharmacol., 390, 319-325 (2000).
16. Li H. Q., Chen W. Z., Ding G. S., Acta Pharmacol. Sin., 6, 91-93 (1985).
17. Chiou W. F., Chou C. J., Shum A. Y. C., Chen C. F., Eur. J. Pharmacol., 215, 277-283 (1992).
18. Rapoport R., Murad F., Circ. Res., 52, 352-357 (1983).
19. Francis S. H., Noblett B. D., Molecular Pharmacology, 34, 506-517 (1988).
20. Cook N. J., Kaupp U. B., Photobiochem. Photobiophys., 13, 331-343 (1986).
21. Broekaert A., Godfraind T., Eur. J. Pharmacol, 53, 281-288 (1979).
22. Saida K., Van Breemen C., Circ. Res., 52, 137-142 (1983).
23. Karaki H., Ozaki H., Hor M., Pharm Rev., 49, 157-230 (1997).
24. Cauvin C., Malik S., J. Pharmacol. Exp. Ther., 230, 413-418 (1984).
25. Heaslip R. J., Rahwan R. G., J. Pharmacol. Exp. Ther., 221, 7-13 (1982).
26. Wilson C., Cooper S. M., Buckingham R. E., J. Cardiovasc. Pharmacol., 9, 401-406 (1987).